Live Deals worth USD 1.50 bn – Buy, Sell, or Raise Funding Today! | Valuation Tool 2.0 – Instant, Data-Backed Company Valuations New | M&A Scorecard & Deal Summary Generator – Assess & Pitch Deals Fast | Post Your Sell-Side or Equity Funding Requirement – Connect Instantly
BUSINESS BRIEF

Established in 2018, this multispeciality hospital is the first in its 100 km region offering critical care and 24/7 emergency services. It has rapidly scaled to a 50-bed capacity, with plans to expand to 200 beds on newly acquired land. The hospital is NABH accredited and equipped with advanced tech such as the Philips Azurion M12 Cath Lab and dedicated Neurosurgery facilities including the region’s first brain and spine microscope.

The hospital operates as an LLP, transitioning soon to a Private Limited Company structure to enable expansion and raise capital.

Products & Services

  • Wide range of medical specialties including Cardiology, Orthopaedics, General Medicine, Urology, Neurosurgery, Gynecology, Psychiatry, and Pediatrics.
  • Full-service diagnostic and pharmacy units integrated with inpatient care.
  • Exclusive superspecialty care not available elsewhere locally, with 24x7 critical care and emergency coverage.
  • Affiliated with major TPAs and government schemes, ensuring broad patient access.

Additional Information

  • Infrastructure & building development: INR 15 Crores
  • New medical equipment & tech upgrades: INR 20 Crores
  • Debt repayment: INR 12.4 Crores
  • Working capital: INR 5 Crores
Proposal
Icon

Industry

Hospitals and Healthcare

Icon

Sub Industry

Hospitals and Extended Care

Icon

Nature of Business

D2C

Icon

Sector

Services

Icon

Reason for sell-off

Strategic Realignment or Pursuing New Opportunities

Icon

Location

India

Icon

Region

Central

Icon

Open For Dilution

100 % (Complete Buyout)

Icon

Top Customer

Icon

Deal Size

INR 45 - 53 Cr

Icon

Justification

Based on market multiple

Business Operation Information
Financial Information
2025 (in INR Cr) 2024 (in INR Cr) 2023 (in INR Cr)
Sales
23 23 17.5
EBITDA
PAT
Business Documents